Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.

Revenue
+3.07%
EPS
−13.5%
Free cash flow
+29.8%
Total debt
−7.50%

Quarter to September 2026, against a year earlier

105.79 1.06 −0.99%
Market cap
$20.4B
P/E
26.9×
Fwd P/E
18.9×
Dividend yield
0.90%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
22.36 20.85 23.36 25.19

+8 more quarters

P/S ratio
1.97 1.94 2.10 2.16
P/FCF ratio
15.16 15.96 17.49 16.53
P/Operating CF
30.22 36.95 49.06 34.41
P/B ratio
1.34 1.31 1.39 1.40
EV/Sales
2.80 2.78 2.93 3.00
EV/EBITDA
10.59 10.21 10.78 11.28
EV/FCF
21.53 22.78 24.48 22.96
Current Ratio
1.46 1.69 1.73 1.98
Net Debt/EBITDA
0.00 11.84 10.96 15.80
Debt/Equity
0.59 0.59 0.59 0.59
Earnings Yield
4.47% 4.80% 4.28% 3.97%
Free Cash Flow Yield
6.60% 6.26% 5.72% 6.05%
Free Cash Flow per Share
1.82 1.28 1.06 1.60
Book value per Share
66.80 65.73 65.03 64.17
Free Cash Flow
347.40 246.00 206.90 315.90
EV/EBIT
20.69 19.60 20.93 22.52
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026